People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EpiVax Therapeutics, Inc. | — | Biotechnology | Seed | $2.6M | $14.8M | 2020 |
| Ceretype Neuromedicine, Inc. | — | Biotechnology | Seed | $1.8M | $1.8M | 2024 |
Richard Lipkin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Lipkin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Adams | 1 | 4 |
| William Martin | 1 | 3 |
| Gad Berdugo | 1 | 2 |
| Emily Stern | 1 | 1 |
| Hong Pan | 1 | 1 |
| David Silbersweig | 1 | 1 |
| Clifford Grimm | 1 | 1 |
| Anne De Groot | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.